Spotlight On... Illumina moves into semiconductor-based sequencing with Project Firefly; FDA introduces draft cybersecurity guidance; Macrogen installs Dragen processors; and more...

Illumina ($ILMN) has outlined its plan to release a semiconductor-based sequencing system. The product, currently dubbed Firefly, will become the first Illumina sequencing system to rely on something other than optical readouts. Illumina signaled its interest in sequencing on complementary metal-oxide semiconductor chips when it bought Avantome back in 2008, but bringing the technology to market has taken time. Illumina expects to install the first Firefly systems in the back half of 2017. Release | Bio-IT World

> The FDA introduced draft guidance on how medical device manufacturers can manage cybersecurity threats. Piece

> Macrogen installed Edico Genome's Dragen processor to accelerate data analysis. Release

> Phlexglobal bought Net Solutions Europe to add to its software development capabilities. News

> 10X Genomics introduced a single-cell genetic analysis product. More

> Ambry Genetics began offering a free version of its genetic data software Progeny Clinical. Item

> The NIH discussed its work to build a major cancer database. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.